Apogee Therapeutics, Inc.
NasdaqGM APGE
Apogee Therapeutics, Inc. Share Price on January 14, 2025: USD 39.34
Apogee Therapeutics, Inc. Share Price is USD 39.34 on January 14, 2025, a 20.79% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.
-
Apogee Therapeutics, Inc. 52-week high Share Price is USD 69.80 on March 13, 2024, which is 77.43% above the current Share Price.
-
Apogee Therapeutics, Inc. 52-week low Share Price is USD 31.60 on January 17, 2024, which is -19.67% below the current Share Price.
-
Apogee Therapeutics, Inc. average Share Price for the last 52 weeks is USD 48.39.
Key data
| Date | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) |
|---|
Market news
Loading...
NasdaqGM: APGE
| CEO | Dr. Michael Thomas Henderson M.D. |
| IPO Date | July 14, 2023 |
| Location | United States |
| Headquarters | 221 Crescent Street |
| Employees | 91 |
| Sector | Health Care |
| Industries | |
Description
Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email